Int. J. Mol. Sci., 2023 · DOI: 10.3390/ijms24010495 · Published: December 28, 2022
Spinal cord injuries (SCI) result in the loss of motor and sensory functions controlled by neurons located at the site of the lesion and below. The study hypothesized that experimentally enhanced remyelination supports axon preservation and/or growth in the total spinal cord transection in rats. Multifocal demyelination was induced by injection of ethidium bromide (EB), either at the time of transection or twice during transection and at 5 days post-injury. The number of oligodendrocyte progenitor cells (OPCs) significantly increased 14 days after demyelination. Behavioral tests revealed significant improvement in locomotor function recovery in double-EB-injected rats, which was impaired by the blockade of serotonin receptors, confirming the important role of restored serotonergic fibers in functional recovery.
Mobilizing endogenous OPCs and/or Schwann cells to migrate into the injury site and enhance remyelination of the affected axons may substantially support their survival and ultimately locomotor recovery.
Recent advances in understanding the complex mechanisms of remyelination and the potential of its modulation, achieved either by pharmacological promotion of endogenous OPC migration and subsequent differentiation, could be employed in spinal cord injury treatment.
Modulating the inflammatory reaction could be also employed in spinal cord injury treatment.